Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma

Previous studies have shown that mithramycin A (MIT) is a promising candidate for the treatment of pancreatic carcinoma through inhibiting transcription factor Sp1. However, systemic toxicities may limit its clinical application. Here, we report a rationally designed formulation of MIT-loaded nanopa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Liu, Xu-Jie, Li, Liang, Liu, Xiu-Jun, Li, Yi, Zhao, Chun-Yan, Wang, Rui-Qi, Zhen, Yong-Su
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5533565/
https://ncbi.nlm.nih.gov/pubmed/28769562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S139507
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars